Mangalam Drugs and Organics Q3FY22 PAT at Rs. 4.02 crore
News

Mangalam Drugs and Organics Q3FY22 PAT at Rs. 4.02 crore

Mangalam Drugs and Organics Limited has reported standalone financial results for the period ended December 31, 2021

  • By IPP Bureau | February 05, 2022

Financial Results (Q3 FY2022) - QoQ comparison

The company has reported total income of Rs. 101.8784 crore during the period ended December 31, 2021 as compared to Rs. 123.0233 crore during the period ended September 30, 2021.

The company has posted net profit of Rs. 4.0222 crore for the period ended December 31, 2021 as against net profit of Rs. 4.5281 crore for the period ended September 30, 2021.

Financial Results (Q3 FY2022) - YoY comparison

The company has reported total income of Rs. 101.8784 crore during the period ended December 31, 2021 as compared to Rs.89.9551 crore during the period ended December 31, 2020.

 The company has posted a net profit of Rs.4.0222 crore for the period ended December 31, 2021 as against a net profit of Rs.6.4342 crore for the period ended December 31, 2020.

Financial Results (nine-month ended FY2022) - YoY comparison

The company has reported total income of Rs.330.2024 crore during the nine-month period ended December 31, 2021 as compared to Rs.291.9604 crore during the nine-month period ended December 31, 2020.

The company has posted net profit of Rs.12.9660 crore for the nine-month period ended December 31, 2021 as against a net profit of Rs.25.8167 crore for the nine-month period ended December 31, 2020.

 

Upcoming E-conference

Other Related stories

Startup

Digitization